Eiger BioPharmaceuticals, Inc.

EIGR | NASDAQ | 0 Sledující

$1.73

0.00%

$0.00

Sledovat

Overview Metrics Financials

Breakdown	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	15,773 +16.98%	13,484 +11.05%	12,142 -
Cost of revenue	24 -98.69%	1,837 +146.58%	745 -
Gross profit	15,749 +35.22%	11,647 +2.19%	11,397 -
Operating expense	87,535 -16.14%	104,387 +18.17%	88,336 -
Operating income	-71,786 +22.59%	-92,740 -20.54%	-76,939 -
Pretax Income	-74,957 +22.53%	-96,753 -185.80%	-33,853 -
Tax Provision	6 -73.91%	23 -64.06%	64 -
Net income	-74,963 +22.54%	-96,776 -185.33%	-33,917 -
EPS	-50.78 +27.19%	-69.74 -7,016.33%	-0.98 -
Diluted EPS	-50.78 +27.19%	-69.74 -7,016.33%	-0.98 -
Average Shares	1,476 +6.39%	1,388 -95.99%	34,632 -
Diluted Average Shares	1,476 +6.39%	1,388 -95.99%	34,632 -
EBIT	-69,491 +24.97%	-92,621 -205.74%	-30,294 -
EBITDA	-68,741 +25.78%	-92,621 -20.38%	-76,939 -

Soubory cookie používáme ke zlepšení prohlížení na webu.